Table 2.
Key characteristics of IDH-wt and IDH-mut glioblastomas
| IDH-wt | IDH-mut | |
|---|---|---|
| Synonym | Primary GBM | Secondary GBM |
| Precursor lesion | Develops de novo | Diffuse astrocytoma, anaplastic astrocytoma |
| Proportion of glioblastomas | ~90% | ~10% |
| Median age at diagnosis | ~62 years | ~44 years |
| Male-to-female ratio | 1.42:1 | 1.05:1 |
| Mean length of clinical history | 4 months | 15 months |
| Median survival | ||
| Surgery, radiotherapy | 9.9 months | 24 months |
| Surgery, radiotherapy, chemotherapy | 15 months | 31 months |
| Location | Supratentorial | Preferentially frontal |
| Necrosis | Extensive | Limited |
| TERT promoter mutations | 72% | 26% |
| TP53 mutations | 27% | 81% |
| ATRX mutations | Exceptional | 71% |
| EGFR amplification | 35% | Exceptional |
| PTEN mutations | 24% | Exceptional |
Table adapted from reference (11).